Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 5.49 USD 1.48% Market Closed
Market Cap: 419.3m USD
Have any thoughts about
Chromadex Corp?
Write Note

Gross Margin
Chromadex Corp

61.5%
Current
61%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
61.5%
=
Gross Profit
56.3m
/
Revenue
91.7m

Gross Margin Across Competitors

Country US
Market Cap 417.4m USD
Gross Margin
61%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 200.4B USD
Gross Margin
41%
Country US
Market Cap 165.1B USD
Gross Margin
60%
Country KR
Market Cap 67.4T KRW
Gross Margin
49%
Country CH
Market Cap 38.1B CHF
Gross Margin
29%
Country US
Market Cap 38.4B USD
Gross Margin
55%
Country US
Market Cap 35.8B USD
Gross Margin
35%
Country US
Market Cap 26.7B USD
Gross Margin
59%
Country US
Market Cap 24B USD
Gross Margin
35%
Country CN
Market Cap 163.2B CNY
Gross Margin
40%
No Stocks Found

Chromadex Corp
Glance View

Market Cap
417.4m USD
Industry
Life Sciences Tools & Services

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

CDXC Intrinsic Value
2.28 USD
Overvaluation 58%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
61.5%
=
Gross Profit
56.3m
/
Revenue
91.7m
What is the Gross Margin of Chromadex Corp?

Based on Chromadex Corp's most recent financial statements, the company has Gross Margin of 61.5%.